Literature DB >> 15056450

Degenerative and regenerative mechanisms governing spinal cord injury.

Christos Profyris1, Surindar S Cheema, DaWei Zang, Michael F Azari, Kristy Boyle, Steven Petratos.   

Abstract

Spinal cord injury (SCI) is a major cause of disability, and at present, there is no universally accepted treatment. The functional decline following SCI is contributed to both direct mechanical injury and secondary pathophysiological mechanisms that are induced by the initial trauma. These mechanisms initially involve widespread haemorrhage at the site of injury and necrosis of central nervous system (CNS) cellular components. At later stages of injury, the cord is observed to display reactive gliosis. The actions of astrocytes as well as numerous other cells in this response create an environment that is highly nonpermissive to axonal regrowth. Also manifesting important effects is the immune system. The early recruitment of neutrophils and at later stages, macrophages to the site of insult cause exacerbation of injury. However, at more chronic stages, macrophages and recruited T helper cells may potentially be helpful by providing trophic support for neuronal and non-neuronal components of the injured CNS. Within this sea of injurious mechanisms, the oligodendrocytes appear to be highly vulnerable. At chronic stages of SCI, a large number of oligodendrocytes undergo apoptosis at sites that are distant to the vicinity of primary injury. This leads to denudement of axons and deterioration of their conductive abilities, which adds significantly to functional decline. By indulging into the molecular mechanisms that cause oligodendrocyte apoptosis and identifying potential targets for therapeutic intervention, the prevention of this apoptotic wave will be of tremendous value to individuals living with SCI.

Entities:  

Mesh:

Year:  2004        PMID: 15056450     DOI: 10.1016/j.nbd.2003.11.015

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  155 in total

1.  The PPAR alpha agonist gemfibrozil is an ineffective treatment for spinal cord injured mice.

Authors:  Akshata Almad; A Todd Lash; Ping Wei; Amy E Lovett-Racke; Dana M McTigue
Journal:  Exp Neurol       Date:  2011-09-21       Impact factor: 5.330

Review 2.  Reactive astrogliosis after spinal cord injury-beneficial and detrimental effects.

Authors:  Soheila Karimi-Abdolrezaee; Rohini Billakanti
Journal:  Mol Neurobiol       Date:  2012-06-09       Impact factor: 5.590

3.  Effect of temperature on spinal cord regeneration in the weakly electric fish, Apteronotus leptorhynchus.

Authors:  Ruxandra F Sîrbulescu; Günther K H Zupanc
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2010-03-26       Impact factor: 1.836

Review 4.  New Insights into the Roles of Nogo-A in CNS Biology and Diseases.

Authors:  Yun-Peng Sui; Xiao-Xi Zhang; Jun-Lin Lu; Feng Sui
Journal:  Neurochem Res       Date:  2015-08-13       Impact factor: 3.996

5.  Acute alterations of glutamate, glutamine, GABA, and other amino acids after spinal cord contusion in rats.

Authors:  Araceli Diaz-Ruiz; Hermelinda Salgado-Ceballos; Sergio Montes; Valente Maldonado; Luis Tristan; Mireya Alcaraz-Zubeldia; Camilo Ríos
Journal:  Neurochem Res       Date:  2006-12-09       Impact factor: 3.996

6.  Mean Arterial Blood Pressure Correlates with Neurological Recovery after Human Spinal Cord Injury: Analysis of High Frequency Physiologic Data.

Authors:  Gregory Hawryluk; William Whetstone; Rajiv Saigal; Adam Ferguson; Jason Talbott; Jacqueline Bresnahan; Sanjay Dhall; Jonathan Pan; Michael Beattie; Geoffrey Manley
Journal:  J Neurotrauma       Date:  2015-08-17       Impact factor: 5.269

7.  The Ryk receptor is expressed in glial and fibronectin-expressing cells after spinal cord injury.

Authors:  Pau González; Carmen María Fernández-Martos; Ernest Arenas; Francisco Javier Rodríguez
Journal:  J Neurotrauma       Date:  2013-05-09       Impact factor: 5.269

8.  The effect of preexisting hypertension on early neurologic results of patients with an acute spinal cord injury.

Authors:  C K Kepler; G D Schroeder; N D Martin; A R Vaccaro; M Cohen; M S Weinstein
Journal:  Spinal Cord       Date:  2015-04-28       Impact factor: 2.772

9.  FK506 Attenuates the Inflammation in Rat Spinal Cord Injury by Inhibiting the Activation of NF-κB in Microglia Cells.

Authors:  Gang Liu; Gentao Fan; Guodong Guo; Wenbo Kang; Dongsheng Wang; Bin Xu; Jianning Zhao
Journal:  Cell Mol Neurobiol       Date:  2016-08-29       Impact factor: 5.046

10.  Scaffolds and stem cells: delivery of cell transplants for retinal degenerations.

Authors:  Karl E Kador; Jeffrey L Goldberg
Journal:  Expert Rev Ophthalmol       Date:  2012-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.